Jan 10, 2022/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Methadone Market.

It was estimated prior to this unanticipated outbreak that the Methadone Market is likely to witness a Healthy CAGR during the forecast period. Pain is one of the most widely recognized ailments and about 85% of individuals are accounted to suffer from pain worldwide at some point in their life. Methadone is a synthetic narcotic analgesic, which is a part of a category known as opioids. This opioid drug has pharmacologic actions qualitatively similar to that of morphine. It is mainly used as a pain reliever and as a part of maintenance therapy and drug addiction detoxification.

The growing prevalence of pain associated with post-surgical and therapeutic treatment of cancer and other chronic diseases is expected to be the prime factor driving the need for methadone.

  • Moreover, rising incidents of opioid abuse and an increasing number of heroin and other drug accustomed people and their treatment that involves short-term administration of methadone hydrochloride further add to the substantial market growth.
  • However, the high risks associated with the usage of methadone over patients suffering from breathing problems and severe asthma is expected to hamper the market expansion.

By route of administration, the global methadone market has been bifurcated into oral and injectable.

  • The oral segment is further segmented into tablets and oral solutions.
  • Under these, the oral segment witnessed the largest market share in 2020 and is likely to register a moderate CAGR in the coming years.
  • This is mainly attributed to the high-performance efficiency and easy availability of the drug in various forms and dosages.

Regional Trends

By region, the North American market garnered the largest market share in 2020 and is likely to register a healthy CAGR during the review period.

  • This is mainly attributed to the higher predominance of the agony and rising incidents of drug addiction, further boosting the regional growth.
  • Moreover, high distress with rising occurrences of people utilization of methadone for chronic post-surgery pains.

Key Players:

Key players operating in the global Methadone market are-

  • Eli Lilly and Company (The U.S),
  • Sanofi (France),
  • Roxane Laboratories (The U.S),
  • Mallinckrodt (UK),
  • Siegfried AG (Switzerland),
  • Johnson Matthey (UK),
  • Tianjin Central Pharma (China),
  • Macfarlan Smith (UK),
  • Vistapharm (The U.S).

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Methadone analysis report discusses the following heads in great detail:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • COVID-19 Impact Assessment
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors 

Know more about Stratview Research:

Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.

Need a detailed report? Get in touch with us: 

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176